Evogene Ltd. (NASDAQ:EVGN) Short Interest Update

Evogene Ltd. (NASDAQ:EVGNGet Free Report) saw a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 135,100 shares, an increase of 503.1% from the October 31st total of 22,400 shares. Based on an average daily volume of 272,900 shares, the days-to-cover ratio is currently 0.5 days. Approximately 2.6% of the company’s stock are sold short.

Evogene Stock Performance

Shares of EVGN traded down $0.08 during mid-day trading on Friday, hitting $1.61. 40,963 shares of the company’s stock were exchanged, compared to its average volume of 89,044. The firm has a fifty day moving average of $2.27 and a two-hundred day moving average of $4.29. Evogene has a twelve month low of $1.44 and a twelve month high of $10.40.

Institutional Trading of Evogene

A hedge fund recently bought a new stake in Evogene stock. Renaissance Investment Group LLC acquired a new position in shares of Evogene Ltd. (NASDAQ:EVGNFree Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 10,000 shares of the biotechnology company’s stock, valued at approximately $31,000. Institutional investors and hedge funds own 10.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on EVGN. Lake Street Capital dropped their price target on shares of Evogene from $30.00 to $12.00 and set a “buy” rating on the stock in a research note on Friday, August 23rd. StockNews.com began coverage on shares of Evogene in a research note on Tuesday. They set a “sell” rating on the stock.

Get Our Latest Stock Analysis on EVGN

About Evogene

(Get Free Report)

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.

Read More

Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.